127 related articles for article (PubMed ID: 9276455)
1. Role of the distal hinge region of C1-inhibitor in the regulation of C1s activity.
He S; Yang JC; Tsang S; Sim RB; Whaley K
FEBS Lett; 1997 Aug; 412(3):506-10. PubMed ID: 9276455
[TBL] [Abstract][Full Text] [Related]
2. A secondary C1s interaction site on C1-inhibitor is essential for formation of a stable enzyme-inhibitor complex.
He S; Sim RB; Whaley K
FEBS Lett; 1997 Mar; 405(1):42-6. PubMed ID: 9094421
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of action of anti-C1-inhibitor autoantibodies: prevention of the formation of stable C1s-C1-inh complexes.
He S; Sim RB; Whaley K
Mol Med; 1998 Feb; 4(2):119-28. PubMed ID: 9508789
[TBL] [Abstract][Full Text] [Related]
4. Polyphosphate is a novel cofactor for regulation of complement by a serpin, C1 inhibitor.
Wijeyewickrema LC; Lameignere E; Hor L; Duncan RC; Shiba T; Travers RJ; Kapopara PR; Lei V; Smith SA; Kim H; Morrissey JH; Pike RN; Conway EM
Blood; 2016 Sep; 128(13):1766-76. PubMed ID: 27338096
[TBL] [Abstract][Full Text] [Related]
5. Epitope mapping of C1 inhibitor autoantibodies from patients with acquired C1 inhibitor deficiency.
He S; Tsang S; North J; Chohan N; Sim RB; Whaley K
J Immunol; 1996 Mar; 156(5):2009-13. PubMed ID: 8596057
[TBL] [Abstract][Full Text] [Related]
6. The potentiation of human C1-inhibitor by dextran sulphate is transient in vivo: studies in a rat model.
Bos IG; van Mierlo GJ; Bleeker WK; Rigter GM; te Velthuis H; Dickneite G; Hack CE
Int Immunopharmacol; 2001 Aug; 1(8):1583-95. PubMed ID: 11515821
[TBL] [Abstract][Full Text] [Related]
7. Fluid-phase interaction of C1 inhibitor (C1 Inh) and the subcomponents C1r and C1s of the first component of complement, C1.
Chesne S; Villiers CL; Arlaud GJ; Lacroix MB; Colomb MG
Biochem J; 1982 Jan; 201(1):61-70. PubMed ID: 6282262
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization of the recombinant human C1 inhibitor serpin domain: insights into heparin binding.
Rossi V; Bally I; Ancelet S; Xu Y; Frémeaux-Bacchi V; Vivès RR; Sadir R; Thielens N; Arlaud GJ
J Immunol; 2010 May; 184(9):4982-9. PubMed ID: 20351192
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of the serpin domain of C1 inhibitor.
Coutinho M; Aulak KS; Davis AE
J Immunol; 1994 Oct; 153(8):3648-54. PubMed ID: 7930585
[TBL] [Abstract][Full Text] [Related]
10. C1 inhibitor-C1s complexes are internalized and degraded by the low density lipoprotein receptor-related protein.
Storm D; Herz J; Trinder P; Loos M
J Biol Chem; 1997 Dec; 272(49):31043-50. PubMed ID: 9388254
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human complement subcomponent C1s lacking beta-hydroxyasparagine, sialic acid, and one of its two carbohydrate chains still reassembles with C1q and C1r to form a functional C1 complex.
Luo C; Thielens NM; Gagnon J; Gal P; Sarvari M; Tseng Y; Tosi M; Zavodszky P; Arlaud GJ; Schumaker VN
Biochemistry; 1992 May; 31(17):4254-62. PubMed ID: 1533159
[TBL] [Abstract][Full Text] [Related]
12. C1 inhibitor hinge region mutations produce dysfunction by different mechanisms.
Davis AE; Aulak K; Parad RB; Stecklein HP; Eldering E; Hack CE; Kramer J; Strunk RC; Bissler J; Rosen FS
Nat Genet; 1992 Aug; 1(5):354-8. PubMed ID: 1363816
[TBL] [Abstract][Full Text] [Related]
13. Substrate properties of C1 inhibitor Ma (alanine 434----glutamic acid). Genetic and structural evidence suggesting that the P12-region contains critical determinants of serine protease inhibitor/substrate status.
Skriver K; Wikoff WR; Patston PA; Tausk F; Schapira M; Kaplan AP; Bock SC
J Biol Chem; 1991 May; 266(14):9216-21. PubMed ID: 2026621
[TBL] [Abstract][Full Text] [Related]
14. Unique C1 inhibitor dysfunction in a kindred without angioedema. I. A mutant C1 INH that inhibits C1-s but not C1-r.
Wisnieski JJ; Knauss TC; Yike I; Dearborn DG; Narvy RL; Naff GB
J Immunol; 1994 Mar; 152(6):3199-209. PubMed ID: 8144914
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the proteolytic activity of the complement protease C1s by polyanions: implications for polyanion-mediated acceleration of interaction between C1s and SERPING1.
Murray-Rust TA; Kerr FK; Thomas AR; Wu T; Yongqing T; Ong PC; Quinsey NS; Whisstock JC; Wagenaar-Bos IC; Freeman C; Pike RN
Biochem J; 2009 Aug; 422(2):295-303. PubMed ID: 19522701
[TBL] [Abstract][Full Text] [Related]
16. Biosynthesis of complement C1 inhibitor by Hep G2 cells. Reactivity of different glycosylated forms of the inhibitor with C1s.
Prandini MH; Reboul A; Colomb MG
Biochem J; 1986 Jul; 237(1):93-8. PubMed ID: 3099750
[TBL] [Abstract][Full Text] [Related]
17. Structure and function of C1 inhibitor.
Davis AE
Behring Inst Mitt; 1989 Jul; (84):142-50. PubMed ID: 2679529
[TBL] [Abstract][Full Text] [Related]
18. [Functions and structure of complement inactivators in plasma. 1). C1 inhibitor].
Yonemasu K
Nihon Rinsho; 1988 Sep; 46(9):1899-903. PubMed ID: 3266510
[No Abstract] [Full Text] [Related]
19. Primary structure of the reactive site of human C1-inhibitor.
Salvesen GS; Catanese JJ; Kress LF; Travis J
J Biol Chem; 1985 Feb; 260(4):2432-6. PubMed ID: 3919001
[TBL] [Abstract][Full Text] [Related]
20. Variability in purified dysfunctional C1(-)-inhibitor proteins from patients with hereditary angioneurotic edema. Functional and analytical gel studies.
Donaldson VH; Harrison RA; Rosen FS; Bing DH; Kindness G; Canar J; Wagner CJ; Awad S
J Clin Invest; 1985 Jan; 75(1):124-32. PubMed ID: 3965500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
